Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice

Journal of Neuroimmunology

Volumn 93, Issue 1-2, 1999, Pages 92-101

  Jones, Richard E ^a,b   Mass, Michele ^b   Bourdette, Dennis N ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

EAE; Lymphocyte deficient; Mouse; MS; Relapse; SCID

Indexed keywords

CD4 ANTIGEN; MYELIN BASIC PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOPATHOLOGY; IMMUNOPATHOLOGY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL TRANSPLANTATION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; IMMUNOPHENOTYPING; MACROPHAGE-1 ANTIGEN; MICE; MICE, SCID; MYELIN BASIC PROTEINS; RECURRENCE; SPINAL CORD; VACCINATION;

EID: 0032892013     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00205-7     Document Type: Article

References (37)

1. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:1989;132-143.
2. Bosma M.J., Carroll A.M. The SCID mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9:1991;323-350.
3. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature. 301:1983;527-530.
4. Cohen J.A., Essayan D.M., Zweiman B., Lisak R.P. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell. Immunol. 108:1987;203-213.
5. Cross A.H., Tuohy V.K., Raine C.S. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:1993;261-269.
6. Cross A.H., O'Mara T., Raine C.S. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology. 43:1998;1028-1033.
7. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
8. Elson C.J., Barker R.N., Thompson S.J., Williams N.A. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol. Today. 16:1995;71-76.
9. Garvey W., Fathi A., Bigelow F., Jimenez C., Carpenter B. A reliable silver impregnation technique for the nervous system. J. Histotechnol. 10:1987;245-247.
10. Jones R.E., Bourdette D.N., Whitham R.H., Offner H., Vandenbark A.A. Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells. J. Immunol. 150:1993;4620-4629.
11. Jones R.E., Whitham R.H., Sullivan T., Mass M., Bourdette D.N. Encephalitogenic T lymphocytes develop from SJL/J hematopoietic cells transplanted into severe combined immunodeficient (SCID) mice. J. Neuroimmunol. 57:1995;155-164.
12. Jones R.E., Chou Y., Young A., Mass M., Vandenbark A., Offner H., Bourdette D. T cells with encephalitogenic potential from multiple sclerosis patients and Lewis rats fail to induce disease in SCID mice following intracisternal injection. J. Neuroimmunol. 56:1995;119-126.
13. Jones R.E., Wesley S., Thompson M., Jacobs R., Bourdette D.N. Phenotype and function of hematopoietic-derived cells in the CNS of SCID mouse-Lewis rat bone marrow chimeras. J. Neuroscience Res. 45:1996;723-734.
14. Kalman B., Knobler R.L., Lublin F.D. T cell receptor V beta gene utilization in myelin basic protein specific clones from CXJ1 recombinant inbred mice. J. Neuroimmunol. 43:1993;191-194.
15. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
16. Knobler R.L., Linthicum D.S., Cohn M. Host genetic regulation of acute MHV-4 viral encephalomyelitis and acute experimental autoimmune encephalomyelitis in (BALB/cKe×SJL/J) recombinant-inbred mice. J. Neuroimmunol. 8:1985;15-28.
17. Lafaille J.J., Van de Keere F., Hsu A.L., Baron J.L., Haas W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease. J. Exp. Med. 186:1997;307-312.
18. Lando Z., Teitelbaum D., Arnon R. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123:1979;2156-2160.
19. Lehmann P.V., Sercarz E.E., Forsthuber T., Dayan C.M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today. 14:1993;203-208.
20. McCarron R.M., Fallis R.J., McFarlin D.E. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:1990;73-79.
21. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 241:1988;1632-1639.
22. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
23. McRae B.L., Karandikar N.J., Miller S.D. Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 75:1997;156-162.
24. Miller S.D., McRae B.L., Vanderlugt C.L., Nikcevich K.M., Pope J.G., Pope L., Karpus W.J. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144:1995;225-244.
25. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745.
26. Mokhtarian F., McFarlin D.E., Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309:1984;356-358.
27. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., Barrett T.A., Miller S.D. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:1997;614-621.
28. Santambrogio L., Crisi G.M., Leu J., Hochwald G.M., Ryan T., Thorbecke G.J. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;211-222.
29. Schuler W., Weiler I.J., Schuler A., Phillips R.A., Rosenberg N., Mak T.W., Kearney J.F., Perry R.P., Bosma M.J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell. 46:1986;963-972.
30. Takacs K., Chandler P., Altmann D.M. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Eur. J. Immunol. 27:1997;2927-2934.
31. Trotter J.L., Clark H.B., Collins K.G., Wegeschiede C.L., Scarpellini J.D. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79:1987;173-188.
32. Voskuhl R.R., Martin R., Bergman C., Dalal M., Ruddle N.H. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity. 15:1993;137-143.
33. Voskuhl R.R., Farris R.W., Nagasato K., McFarland H.F., Dalcq M.D. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein. J. Neuroimmunol. 70:1996;103-111.
34. Weinberg A.D., Wyrick G., Celnik B., Vainiene M., Bakke A., Offner H., Vandenbark A.A. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is associated with a host recruited CD45R hi/CD4+ population during recovery. J. Neuroimmunol. 48:1993;105-118.
35. Weinberg A.D., Wallin J.J., Jones R.E., Sullivan T.J., Bourdette D.N., Vandenbark A.A., Offner H. Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152:1994;4712-4721.
36. Whitham R.H., Kotzin B.L., Buenafe A.C., Weinberg A.D., Jones R.E., Hashim G.A., Hoy C.M., Vandenbark A.A., Offner H. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J. Neuroscience Res. 35:1993;115-128.
37. Yu M., Johnson J.J., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1996;1777-1788.